Furthermore, they also observed a dose-dependent inhibition of the expression of ATG16L1, decreasing ATG16L1-induced autophagy and activating NLRP3 inflammasome, which has been recently found to be critical for the development of atherosclerosis and has been also linked to AD [89,90]. The gene discussed is ATG16L1; the disease is Alzheimer disease.